DXCM vs VNO · P/E 63, rev $2.50B vs rev $921.3M
DexCom Inc (DXCM) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
VNO (VNO) common stock.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. VNO currently screens at market cap $0.
Not investment advice. Open the DXCM and VNO stock pages for the full models.
Not investment advice.